Eric Klann is Professor and Director of the Center for Neural Science at New York University. Dr. Klann received his Ph.D. from Virginia Commonwealth Univeristy School of Medicine in 1989, did postdoctoral training at Baylor College of Medicine with Dr. David Sweatt, and previously held faculty positions at the University of Pittsburgh and Baylor College of Medicine. Dr. Klann’s research is focused on the molecular mechanisms of translational control and their role in activity-dependent changes in synaptic function and behavior, including cognition. He also studies how dysregulated translational control contributes to altered synaptic function and aberrant behaviors in developmental brain disorders and neurodegenerative disease. Dr. Klann has published over 160 original research articles, reviews, commentaries, and book chapters. Dr. Klann serves as a Reviewing Editor for the Journal of Neuroscience, a Section Editor for Brain Research, and serves on the editoral boards of several other journals. He is a former member and chair of the Neural Oxidative Metabolism & Death and Molecular & Cellular Substrates of Complex Disorders Study Sections of the National Institutes of Health. Dr. Klann serves on the Scientific Advisory Boards for the Pitt Hopkins Syndrome Foundation and the Foundation for Angelman Syndrome Therapeutics, where he is also the Chair. He also has served on the Fragile X Outcomes Measures and TSC Neurocognitive Working Groups for the National Institutes of Health. Dr. Klann has served as the Treasurer and the President of the Molecular and Cellular Cognition Society. He is the recipient of a NARSAD Distinguished Investigator Award and the Jacob Javits Neuroscience Investigator Award from the National Instittutes of Neurological Disorders and Stroke, and is a Fellow of the American Association for the Advancement of Science.